My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing

Best Coronavirus Vaccine Stocks

Compare coronavirus vaccine stocks. These companies are COVID-19 vaccine frontrunners. Get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.
Compare up to 10 stocks

Comparison Results

Name
Price
Price Change
Price Target Upside
Market Cap
Yearly Gain
Analyst Consensus
Smart Score
Follow
PFEPfizer
$42.09
0.77 (1.86%)
$45.38
(7.82% Upside)
$235.99B
20.08%
2Buy
10Hold
0Sell
Hold
premium
MRNAModerna
$333.61
-1.23 (-0.37%)
$341.88
(2.48% Upside)
$134.66B
371.87%
5Buy
6Hold
2Sell
Hold
premium
BNTXBioNTech SE
$262.85
1.76 (0.67%)
$346.25
(31.73% Upside)
$63.75B
177.99%
3Buy
5Hold
0Sell
Moderate Buy
premium
JNJJohnson & Johnson
$163.87
3.75 (2.34%)
$193.00
(17.78% Upside)
$431.38B
13.79%
5Buy
2Hold
0Sell
Moderate Buy
premium
AZNAstraZeneca
$60.17
0.88 (1.48%)
$73.00
(21.32% Upside)
$186.42B
16.10%
2Buy
0Hold
0Sell
Moderate Buy
premium
NVAXNovavax
$160.55
-5.7 (-3.43%)
$290.33
(80.83% Upside)
$11.96B
62.91%
3Buy
0Hold
0Sell
Strong Buy
premium
INOInovio Pharmaceuticals
$7.13
0.11 (1.57%)
$11.67
(63.67% Upside)
$1.50B
-38.15%
1Buy
2Hold
1Sell
Hold
premium

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Coronavirus Vaccine Stocks Latest News

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Coronavirus Vaccine Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
NVAXNovavax
premium
premium
Buy
premium
premium
Reiterated
JNJJohnson & Johnson
premium
premium
Buy
premium
premium
Reiterated
MRNAModerna
premium
premium
Buy
premium
premium
Upgraded
AZNAstraZeneca
premium
premium
Buy
premium
premium
Reiterated
PFEPfizer Inc
premium
premium
Hold
premium
premium
Reiterated
BNTXBiontech Se Sponsored Adr
premium
premium
Hold
premium
premium
Initiated
INOInovio Pharmaceuticals
premium
premium
Sell
premium
premium
Downgraded
MRNAModerna
premium
premium
Buy
premium
premium
Upgraded
MRNAModerna
premium
premium
Buy
premium
premium
Reiterated
MRNAModerna
premium
premium
Hold
premium
premium
Reiterated

Most Recent Earnings of Coronavirus Vaccine Stocks

SYMBOL
Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
PFEPfizer
Jul 28, 2021
2021 (Q2)
0.97 / 0.98
0.61
60.66% (+0.37)
MRNAModerna
Aug 05, 2021
2021 (Q2)
5.96 / 6.45
-0.307
2200.98% (+6.76)
BNTXBioNTech SE
Aug 09, 2021
2021 (Q2)
8.77 / 13.86
-0.418
3414.83% (+14.27)
JNJJohnson & Johnson
Jul 21, 2021
2021 (Q2)
2.29 / 2.35
1.36
72.79% (+0.99)
AZNAstraZeneca
Jul 29, 2021
2021 (Q2)
0.44 / 0.21
0.288
-27.08% (-0.08)
NVAXNovavax
Aug 05, 2021
2021 (Q2)
-3.63 / -4.75
-0.299
-1489.97% (-4.45)
INOInovio Pharmaceuticals
Aug 09, 2021
2021 (Q2)
-0.25 / -0.39
-0.826
52.54% (+0.43)

Coronavirus Vaccine Stocks - FAQ

Which Coronavirus Vaccine stocks have a "Strong Buy" analyst rating?
These Coronavirus Vaccine stocks currently have a "Strong Buy" analyst rating consensus:
Novavax - Strong Buy, based on 3 analyst ratings, 3 Buy, 0 Hold, and 0 Sell.
    Are Coronavirus Vaccine stocks overpriced?
    Pfizer's stock price is currently $42.09, and its average 12-month price target is $45.38.
      Moderna's stock price is currently $333.61, and its average 12-month price target is $341.88.
        BioNTech SE's stock price is currently $262.85, and its average 12-month price target is $346.25.
          Johnson & Johnson's stock price is currently $163.87, and its average 12-month price target is $193.00.
            AstraZeneca's stock price is currently $60.17, and its average 12-month price target is $73.00.
              Novavax's stock price is currently $160.55, and its average 12-month price target is $290.33.
                Inovio Pharmaceuticals's stock price is currently $7.13, and its average 12-month price target is $11.67.
                  Which Coronavirus Vaccine stocks pay dividends?
                  Pfizer currently pays a dividend of $0.39 which represents an annual dividend yield of 3.75%. Pfizer's next Ex-dividend date is November 4, 2021 and its next payout date is December 6, 2021.
                    Moderna does not currently pay dividends.
                      BioNTech SE does not currently pay dividends.
                        Johnson & Johnson does not currently pay dividends.
                          AstraZeneca does not currently pay dividends.
                            Novavax does not currently pay dividends.
                              Inovio Pharmaceuticals does not currently pay dividends.